Overview

• LOY-002 is a meat-flavored daily pill for dogs aged 10 and older designed to target metabolic aging and potentially extend healthy lifespan by up to ten years.
• Initial safety studies dosed over 400 dogs for three months with no clinically significant adverse effects.
• The double-blind STAY trial is under way in 70 U.S. veterinary clinics to assess LOY-002’s efficacy in senior dogs.
• Loyal has secured over $150 million in investment and plans to seek conditional FDA approval for LOY-002 in 2026.
• The company is advancing LOY-001, a long-acting injectable, and LOY-003, a daily pill for larger breeds, toward conditional FDA approval in 2027.